Cytek Biosciences Stock Price History
CTKB Stock | USD 3.13 0.17 5.15% |
If you're considering investing in Cytek Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cytek Biosciences stands at 3.13, as last reported on the 19th of July, with the highest price reaching 3.34 and the lowest price hitting 3.10 during the day. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of -0.026, which signifies that the company had a -0.026 % return per unit of risk over the last 3 months. Cytek Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytek Biosciences' Mean Deviation of 3.27, standard deviation of 5.0, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. At present, Cytek Biosciences' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.14, whereas Total Stockholder Equity is forecasted to decline to about 286.5 M. . At present, Cytek Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 3.03, whereas Price To Sales Ratio is forecasted to decline to 4.02. Cytek Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sharpe Ratio = -0.026
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CTKB |
Estimated Market Risk
5.16 actual daily | 46 54% of assets are more volatile |
Expected Return
-0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cytek Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytek Biosciences by adding Cytek Biosciences to a well-diversified portfolio.
Price Book 1.101 | Enterprise Value Ebitda (133.96) | Price Sales 2.1212 | Shares Float 108.2 M | Wall Street Target Price 5.75 |
Cytek Biosciences Stock Price History Chart
There are several ways to analyze Cytek Stock price data. The simplest method is using a basic Cytek candlestick price chart, which shows Cytek Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | April 28, 2025 | 3.86 |
Lowest Price | May 23, 2025 | 2.42 |
Cytek Biosciences July 19, 2025 Stock Price Synopsis
Various analyses of Cytek Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cytek Stock. It can be used to describe the percentage change in the price of Cytek Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cytek Stock.Cytek Biosciences Price Rate Of Daily Change | 0.95 | |
Cytek Biosciences Price Action Indicator | (0.18) | |
Cytek Biosciences Price Daily Balance Of Power | (0.71) | |
Cytek Biosciences Accumulation Distribution | 51,358 |
Cytek Biosciences July 19, 2025 Stock Price Analysis
Cytek Stock Price History Data
The price series of Cytek Biosciences for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 1.44 with a coefficient of variation of 12.8. The prices are distributed with arithmetic mean of 3.3. The median price for the last 90 days is 3.4.Open | High | Low | Close | Volume | ||
07/18/2025 | 3.34 | 3.34 | 3.10 | 3.13 | 714,730 | |
07/17/2025 | 3.26 | 3.38 | 3.25 | 3.30 | 775,307 | |
07/16/2025 | 3.29 | 3.34 | 3.22 | 3.24 | 788,508 | |
07/15/2025 | 3.36 | 3.40 | 3.21 | 3.25 | 1,147,279 | |
07/14/2025 | 3.41 | 3.44 | 3.26 | 3.35 | 1,016,967 | |
07/11/2025 | 3.53 | 3.55 | 3.43 | 3.45 | 441,456 | |
07/10/2025 | 3.54 | 3.63 | 3.48 | 3.56 | 642,705 | |
07/09/2025 | 3.47 | 3.62 | 3.46 | 3.58 | 862,398 | |
07/08/2025 | 3.40 | 3.48 | 3.26 | 3.43 | 2,459,205 | |
07/07/2025 | 3.71 | 3.72 | 3.39 | 3.40 | 743,911 | |
07/03/2025 | 3.62 | 3.82 | 3.59 | 3.76 | 776,901 | |
07/02/2025 | 3.47 | 3.68 | 3.45 | 3.61 | 850,710 | |
07/01/2025 | 3.40 | 3.60 | 3.38 | 3.48 | 1,129,459 | |
06/30/2025 | 3.55 | 3.62 | 3.40 | 3.40 | 1,153,471 | |
06/27/2025 | 3.55 | 3.65 | 3.42 | 3.55 | 1,500,901 | |
06/26/2025 | 3.35 | 3.63 | 3.32 | 3.55 | 1,511,367 | |
06/25/2025 | 3.20 | 3.38 | 3.12 | 3.33 | 1,124,034 | |
06/24/2025 | 3.17 | 3.28 | 3.13 | 3.23 | 1,435,779 | |
06/23/2025 | 2.92 | 3.14 | 2.90 | 3.12 | 1,678,784 | |
06/20/2025 | 3.11 | 3.13 | 2.94 | 2.95 | 1,773,542 | |
06/18/2025 | 3.17 | 3.26 | 3.06 | 3.07 | 1,490,593 | |
06/17/2025 | 3.25 | 3.30 | 3.10 | 3.19 | 1,641,274 | |
06/16/2025 | 3.26 | 3.35 | 3.17 | 3.30 | 1,490,974 | |
06/13/2025 | 3.26 | 3.35 | 3.16 | 3.22 | 1,299,788 | |
06/12/2025 | 3.37 | 3.45 | 3.35 | 3.36 | 894,304 | |
06/11/2025 | 3.52 | 3.57 | 3.42 | 3.44 | 973,475 | |
06/10/2025 | 3.52 | 3.59 | 3.44 | 3.47 | 1,170,668 | |
06/09/2025 | 3.46 | 3.72 | 3.46 | 3.56 | 2,716,600 | |
06/06/2025 | 3.34 | 3.47 | 3.33 | 3.44 | 1,566,203 | |
06/05/2025 | 3.41 | 3.53 | 3.26 | 3.34 | 3,049,948 | |
06/04/2025 | 2.96 | 3.43 | 2.96 | 3.40 | 2,919,737 | |
06/03/2025 | 2.81 | 2.88 | 2.76 | 2.85 | 1,130,077 | |
06/02/2025 | 2.77 | 2.86 | 2.62 | 2.83 | 2,723,189 | |
05/30/2025 | 2.57 | 2.82 | 2.54 | 2.77 | 1,564,994 | |
05/29/2025 | 2.50 | 2.60 | 2.46 | 2.59 | 1,037,236 | |
05/28/2025 | 2.55 | 2.57 | 2.44 | 2.49 | 1,139,980 | |
05/27/2025 | 2.45 | 2.61 | 2.43 | 2.57 | 1,526,613 | |
05/23/2025 | 2.41 | 2.46 | 2.37 | 2.42 | 914,867 | |
05/22/2025 | 2.50 | 2.53 | 2.39 | 2.45 | 1,367,621 | |
05/21/2025 | 2.63 | 2.65 | 2.47 | 2.48 | 803,106 | |
05/20/2025 | 2.54 | 2.73 | 2.51 | 2.66 | 1,061,645 | |
05/19/2025 | 2.65 | 2.71 | 2.59 | 2.69 | 922,193 | |
05/16/2025 | 2.66 | 2.68 | 2.52 | 2.67 | 1,443,207 | |
05/15/2025 | 2.73 | 2.76 | 2.60 | 2.68 | 1,083,661 | |
05/14/2025 | 2.95 | 2.95 | 2.73 | 2.73 | 1,221,657 | |
05/13/2025 | 3.05 | 3.10 | 2.82 | 2.98 | 1,257,181 | |
05/12/2025 | 3.06 | 3.16 | 2.97 | 3.02 | 1,231,057 | |
05/09/2025 | 3.10 | 3.47 | 2.87 | 2.93 | 2,223,557 | |
05/08/2025 | 3.79 | 3.89 | 3.71 | 3.79 | 675,544 | |
05/07/2025 | 3.74 | 3.80 | 3.67 | 3.73 | 614,500 | |
05/06/2025 | 3.70 | 3.80 | 3.64 | 3.68 | 625,186 | |
05/05/2025 | 3.84 | 3.89 | 3.79 | 3.80 | 492,410 | |
05/02/2025 | 3.77 | 3.88 | 3.75 | 3.86 | 497,366 | |
05/01/2025 | 3.74 | 3.87 | 3.62 | 3.70 | 418,899 | |
04/30/2025 | 3.68 | 3.75 | 3.61 | 3.71 | 455,174 | |
04/29/2025 | 3.84 | 3.85 | 3.70 | 3.75 | 444,528 | |
04/28/2025 | 3.79 | 3.87 | 3.76 | 3.86 | 612,649 | |
04/25/2025 | 3.77 | 3.86 | 3.73 | 3.77 | 590,832 | |
04/24/2025 | 3.79 | 3.82 | 3.73 | 3.82 | 740,703 | |
04/23/2025 | 3.90 | 4.05 | 3.76 | 3.77 | 600,457 | |
04/22/2025 | 3.76 | 3.83 | 3.72 | 3.79 | 505,353 |
About Cytek Biosciences Stock history
Cytek Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytek is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytek Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytek Biosciences stock prices may prove useful in developing a viable investing in Cytek Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 130.6 M | 107.2 M | |
Net Income Applicable To Common Shares | 3 M | 3.1 M |
Cytek Biosciences Quarterly Net Working Capital |
|
Cytek Biosciences Stock Technical Analysis
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
All Next | Launch Module |
Cytek Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytek Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cytek Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytek to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.41) | |||
Total Risk Alpha | (0.86) | |||
Treynor Ratio | (0.08) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |